Abbas Samaha, Jacques Choucair*, Gebrayel Saliba, Nabil Chehata, Marie Chedid and Racha Ibrahim
Saint Joseph University, Faculty of Medicine, Infectious Diseases Department, Hotel Dieu de France, Beyrouth, The Lebanon
*Corresponding Author: Jacques Choucair, Saint Joseph University, Faculty of Medicine, Infectious Diseases Department, Hotel Dieu de France, Beyrouth, The Lebanon.
Received: December 07, 2022; Published: January 24, 2023
Introduction: During the last few years, the emergence of carbapenemase producing gram-negative bacteria infections has been reported worldwide. These infections are very difficult to treat since there is no consensus on the antibiotic treatment modalities.
Methods: This study is an observational, retrospective study reviewing the clinical course and prognosis of patients treated for carbapenemase secreting Enterobacteriaceae infection, according to different antibiotic treatment protocols. The population consists of all patients infected by enterobacteriaceae with a decreased sensitivity to carbapenems, between September 2014 and January 2016. The primary objective of this study is to compare the recurrence and mortality rates between the group of patients treated with a monotherapy and the one receiving a combination antibiotic therapy.
Results: Amongst the 29 patients that received a monotherapy, 15 patients (51.7%) had a recurrent infection compared to 9 patients (33.3%) out of 27 that received a combination therapy without a statistically significant difference between these 2 groups. The interval of trust is [0,16- 1,38] (p-value at 0.467 > 0.05).
10 patients (34.5%) out of the 29 patients who received a single antibiotic died compared to 14 (51.9%) of the 27 patients who received a combined antibiotherapy. There was no statistical significant difference between these 2 groups: [0,7-6] is the interval of trust for this analysis with a p-value at 2.046 > 0.05.
Conclusions: The number of antibiotics used, whether one or more, does not influence the recurrence rate of carbapenemase-secreting enterobacteriaceae. And the type of therapy used, has no effect on the mortality rate, following a carbapenemase-secreting enterobacteriaceae.
Keywords: Penicillin G; Carbapenemase; Enzymes
Citation: Jacques Choucair., et al. “Clinical Evolution of Carbapenemase Producing Gram-negative Bacteria Infections Treated by Monotherapy Versus Dual Therapy". Acta Scientific Microbiology 6.2 (2023): 86-91.
Copyright: © 2022 Jacques Choucair., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.